This website is intended for healthcare professionals only

touchCARDIO

Search

Arrhythmia Interventional Cardiology

Haran Burri, EHRA 2021: The Future of Pacing

Haran Burri

6.23

Published Online: May 5th 2021

Prof. Haran Burri (Lead Cardiac Physiologist, University of Oxford, Oxford, UK) gave us an update on the future of pacing from the European Heart Rhythm Association (EHRA) Virtual Meeting 2021.

Questions:

What is the potential role of conduction system pacing as an alternative to biventricular pacing? (0.21)
What have we learned from early clinical experience of leadless pacemakers and how is this technology likely to develop? (3.32)

Speaker disclosures: Prof. Haran Burri has received institutional fellowship and research support and speaker fees from Abbott, Biotronik, Boston Scientific, Medtronic and Microport.

Interview and filming supported by Touch Medical Media. Interview conducted by Heather Hall.

Filmed during a remote video call with Prof. Haran Burri as a highlight of EHRA 2021, May 2021

Trending Topic

Developed by Touch

EuroPCR 2026: Selected late-breaking trials from Day 3

New late-breaking data presented on Day 3 of EuroPCR 2026 highlighted evolving approaches to antiplatelet therapy, transcatheter treatment of pure aortic regurgitation and procedural optimization in bicuspid TAVR

Related Videos in Interventional Cardiology

Developed by Touch

BIO LIBRA: ICD versus CRTD in Non-ischaemic Cardiomyopathy Outcomes by Sex

Valentina Kutyifa

In this interview, Dr Valentina Kutyifa, University of Rochester Medical Center, Rochester, NY, USA, offers insight into the BIO LIBRA study (ClinicalTrials.gov identifier: NCT03884608), a landmark trial designed to reassess outcomes in patients with non-ischaemic cardiomyopathy in the era of contemporary medical therapy. Recognizing that much of the original evidence supporting implantable cardioverter-defibrillator (ICD) use in this population dates back decades, the BIO LIBRA study was initiated to fill key knowledge gaps using modern treatment protocols.

Developed by Touch

PRAETORIAN XL: Long-Term Outcomes of Subcutaneous versus Transvenous ICD Therapy

Louise Olde Nordkamp

In this interview, Dr Louise Olde Nordkamp, a device cardiologist at Amsterdam University Medical Center, discusses the long-term findings of the PRAETORIAN XL trial—a follow-up study comparing transvenous and subcutaneous implantable cardioverter-defibrillators (ICDs). Building on the original PRAETORIAN trial, this extended 8-year analysis evaluated device-related complications and confirmed that subcutaneous ICDs carry fewer major and lead-related complications. Dr Olde Nordkamp highlights the clinical relevance of these results, supporting broader consideration of subcutaneous ICDs in patients without pacing indications.

Developed by Touch

Conduction system pacing versus biventricular resynchronization therapy in systolic dysfunction and wide QRS: CONSYST-CRT

Margarida Pujol-Lopez

In this interview, Dr. Margarida Pujol-Lopez from the Hospital Clinic in Barcelona discusses the differences between conduction system pacing (CSP) and biventricular pacing (BVP) in treating heart failure. CSP is more physiological and may offer better outcomes than BVP, which fails in about 30% of patients. The CONSYST-CRT trial, comparing CSP and BVP, showed that CSP is non-inferior to BVP based on primary and secondary endpoints, including mortality, heart failure, and QRS shortening.

Developed by Touch

Ischaemic left ventricular systolic dysfunction: REVIVED-BCIS2 and STICH trials

Guillaume Marquis-Gravel

Revascularization for patients with ischaemic left ventricular (LV) systolic dysfunction takes one of two forms - percutaneous coronary intervention (PCI) and coronary artery bypass graft (CABG), both of which have positives and negatives. STICH, published in 2011, analysed the role of CABG in patients with LV systolic dysfunction and looked at improvement of clinical outcomes in 1,212 patients from 22 countries across the world, optimised to either optimal medical therapy or optimal medical therapy plus CABG. REVIVED-BCIS2 in 2022 looked at 700 patients in the UK with a similar patient population of 35% ejection fraction or less, randomized to PCI or optimal medical therapy. This interview dives into their analysis of the results from these exciting trials and investigation into the discrepancies between the outcomes.

Developed by Touch

Sem Briongos Figuero, EHRA 2023: The OptiVALL study, assessing the Micra AV device for atrioventricular synchronous pacing

The OptiVALL study aimed to assess the atrioventricular synchronous pacing capabilities of the Micra AV device, and to describe what programming changes are needed. In this touchCARDIO interview, we speak with Dr Sem Briongos Figuero (Hospital Infanta Leonor, Madrid, Spain) ...

Developed by Touch

Sem Briongos Figuero, EHRA 2023: Clinical trials studying atrioventricular synchronous pacing, and the limitations

The MARVEL 2 trial studied atrioventricular synchronous pacing in patients with a Micra leadless ventricular pacemaker. In this touchCARDIO interview, we speak with Dr Sem Briongos Figuero (Hospital Infanta Leonor, Madrid, Spain) to discuss the trials studying atrioventricular synchrony and their ...

Developed by Touch

Gregg Stone, ACC 2023: Transcatheter edge-to-edge repair for functional mitral regurgitation in heart failure

Transcatheter edge-to-edge repair (TEER) is a minimally invasive procedure that can effectively treat functional mitral regurgitation in heart failure patients. Compared to traditional surgical approaches, TEER offers benefits such as reduced hospital stay, lower risk of bleeding and infection, and ...

Developed by Touch

Gregg Stone, ACC 2023: COAPT trial results - Transcatheter edge-to-edge repair with MitraClip device for functional mitral regurgitation in heart failure

The COAPT trial investigated the use of the MitraClip a novel device for patients with secondary mitral regurgitation, a condition in which blood leaks backward through the mitral valve into the left atrium of the heart. In this touchCARDIO interview ...

Andrew Krahn: Heart Rhythm 2023 & HRX 2023 - The latest Innovations in arrhythmia care and technology

Dr Andrew Krahn, President, Heart Rhythm Society (HRS), discusses the upcoming Heart Rhythm 2023 meeting (May 19-21, 2023, New Orleans, LA, USA), and the HRX 2023 conference (September 21-23, 2023, in Seattle, WA, USA) hosted by the Heart Rhythm Society (HRS), a non-profit organization ...

Developed by Touch

Hyo-Soo Kim, ACC 2023: Guidelines for the use of short-term dual antiplatelet therapy after coronary intervention

The guidelines for the use of short-term dual antiplatelet therapy (DAPT) after coronary intervention vary depending on the patient's clinical situation and the type of intervention performed. In this touchCARDIO interview, we speak with Prof. Hyo-Soo Kim (Department of Internal ...

Developed by Touch

Hyo-Soo Kim, ACC 2023: HOST IDEA trial - Short-term dual antiplatelet therapy non-inferior to 12 Months after PCI with third-generation drug-eluting stents

The goal of dual antiplatelet therapy (DAPT) is to reduce the risk of stent thrombosis, a potentially life-threatening complication that can occur when blood clots form in the stent. In this touchCARDIO interview, we speak with Prof. Hyo-Soo Kim (Department ...

Developed by Touch

Steven Messe, TCT 2022: Sentinel® cerebral protection system efficacy in reducing all stroke/disabling stroke, the PROTECTED-TAVR trial (a neurologist’s perspective)

The PROTECTED-TAVR trial studied the efficacy of using an embolic protection device (Sentinel® cerebral protection system) during transcatheter aortic valve replacement in reducing the incidence of stroke/disabling stroke. In this touchCARDIO interview, we speak with Dr Steven Messe (University ...

Latest articles videos and clinical updates - straight to your inbox

Sign Up

Login

Sign Up FREE

Log into your Touch Account

Keep track of your clinical interests and newsletter subscriptions.

Error:

Forgot Password?

Or log in with

By proceeding, you agree to our terms & conditions.

For information about how we
use your data, see our privacy policy.

Register now for FREE Access

Register for free to hear about the latest expert-led education, peer-reviewed articles, conference highlights, and innovative CME activities.

Sign up with an Email

Sign up with Google

Sign up with Facebook

Sign up with LinkedIn

Sign up with Microsoft

Already have an Account?

Login

Sign up with an Email

Or use a Social Account.

Error:

By clicking sign up you agree to the website
terms & conditions and privacy policy.

Register now for FREE access

Already registered? Login below.

Register

Login